TG · Company research
Tredegar Corporation (TG): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
20records availableBasic Materials
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Tredegar grants director 1,583 shares of Tredegar stock - ad-hoc-news.de | Tredegar grants director 1,583 shares of Tredegar stock ad-hoc-news.de | View source ↗ | ad-hoc-news.de | Oct 18, 2026 | neutral | 0 | 0.6 |
| Five Year MS Data Might Change The Case For Investing In TG Therapeutics Stock (TGTX) - Simply Wall Street | Five Year MS Data Might Change The Case For Investing In TG Therapeutics Stock (TGTX) Simply Wall Street | View source ↗ | Simply Wall Street | Oct 17, 2026 | neutral | 0 | 0.6 |
| Understanding the Setup: (TG) and Scalable Risk - Stock Traders Daily | Understanding the Setup: (TG) and Scalable Risk Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 17, 2026 | neutral | 0 | 0.6 |
| Tg Therapeutics Stock Price Forecast. Should You Buy TGTX? - StockInvest.us | Tg Therapeutics Stock Price Forecast. Should You Buy TGTX? StockInvest.us | View source ↗ | StockInvest.us | Oct 16, 2026 | neutral | 0 | 0.6 |
| TGTX Stock Rises 60% in 6 Months: Here's What You Should Know - TradingView | TGTX Stock Rises 60% in 6 Months: Here's What You Should Know TradingView | View source ↗ | TradingView | Oct 13, 2026 | neutral | 0 | 0.6 |
| TGTX Stock Rises 60% in 6 Months: Here's What You Should Know - TradingView | TGTX Stock Rises 60% in 6 Months: Here's What You Should Know TradingView | View source ↗ | TradingView | Oct 13, 2026 | neutral | 0 | 0.6 |
| TG Therapeutics Inc (NKB2.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada | TG Therapeutics Inc (NKB2.DU) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 13, 2026 | neutral | 0 | 0.6 |
| A five-year analysis estimated disability progression at 9.4% with BRIUMVI, versus 17.9% with ofatumumab - Stock Titan | A five-year analysis estimated disability progression at 9.4% with BRIUMVI, versus 17.9% with ofatumumab Stock Titan | View source ↗ | Stock Titan | Oct 12, 2026 | neutral | 0 | 0.6 |
| TG Therapeutics (NasdaqCM:TGTX) Stock Forecast & Analyst Predictions - Simply Wall Street | TG Therapeutics (NasdaqCM:TGTX) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 9, 2026 | neutral | 0 | 0.6 |
| TG Therapeutics (TGTX) Stock May Be Undervalued Despite Fresh Newsflow - Yahoo Finance | TG Therapeutics (TGTX) Stock May Be Undervalued Despite Fresh Newsflow Yahoo Finance | View source ↗ | Yahoo Finance | Oct 9, 2026 | neutral | 0 | 0.6 |
| First results from a cell therapy for progressive multiple sclerosis are scheduled for Oct. 23. - Stock Titan | First results from a cell therapy for progressive multiple sclerosis are scheduled for Oct. 23. Stock Titan | View source ↗ | Stock Titan | Oct 8, 2026 | neutral | 0 | 0.6 |
| Who's Buying or Selling TG Therapeutics Inc (TGTX) Stock Today? - GuruFocus | Who's Buying or Selling TG Therapeutics Inc (TGTX) Stock Today? GuruFocus | View source ↗ | GuruFocus | Oct 8, 2026 | neutral | 0 | 0.6 |
| TG Therapeutics (NASDAQ:TGTX) Emerges as an Affordable Growth Play in Biotech - ChartMill | TG Therapeutics (NASDAQ:TGTX) Emerges as an Affordable Growth Play in Biotech ChartMill | View source ↗ | ChartMill | Oct 5, 2026 | neutral | 0 | 0.6 |
| TG Therapeutics (TGTX) Stock May Be Below Fair Value As BRIUMVI Gains Share - Simply Wall Street | TG Therapeutics (TGTX) Stock May Be Below Fair Value As BRIUMVI Gains Share Simply Wall Street | View source ↗ | Simply Wall Street | Sep 25, 2026 | neutral | 0 | 0.6 |
| IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point - Investor's Business Daily | IBD Stock Of The Day, TG Therapeutics, Eyes Breakout After Topping Early Buy Point Investor's Business Daily | View source ↗ | Investor's Business Daily | Sep 2, 2026 | neutral | 0 | 0.6 |
| Insider Sale: 10% owner at $TG Sells 7,719 Shares - Quiver Quantitative | Insider Sale: 10% owner at $TG Sells 7,719 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 19, 2026 | neutral | 0 | 0.6 |
| Tredegar (TG) Stock Rebounds As Profit Returns Despite Five Year Earnings Slide - Simply Wall Street | Tredegar (TG) Stock Rebounds As Profit Returns Despite Five Year Earnings Slide Simply Wall Street | View source ↗ | Simply Wall Street | Aug 9, 2026 | neutral | 0 | 0.6 |
| How Roche Unexpectedly Buoyed IBD Stock Of The Day TG Therapeutics - Investor's Business Daily | How Roche Unexpectedly Buoyed IBD Stock Of The Day TG Therapeutics Investor's Business Daily | View source ↗ | Investor's Business Daily | Jul 24, 2026 | neutral | 0 | 0.6 |
| Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now? - Yahoo Finance | Is TG Therapeutics, Inc. (TGTX) A Good Stock To Buy Now? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 19, 2026 | neutral | 0 | 0.6 |
| Why This IBD Stock Of The Day, A Roche Rival, Just Broke Out To A Five-Year High - Investor's Business Daily | Why This IBD Stock Of The Day, A Roche Rival, Just Broke Out To A Five-Year High Investor's Business Daily | View source ↗ | Investor's Business Daily | Jun 10, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.